Squamous cell cancer of the scalp
Case of Dr. Hernán Jaramillo Botero on CDS Treatment and Pediatric Nutrition Experience
Dr. Hernán Jaramillo Botero, a 91-year-old physician from Colombia, shares his testimony regarding the therapeutic use of chlorine dioxide solution (CDS) in the treatment of advanced squamous cell carcinoma, as well as his pioneering work in pediatric nutrition.
Clinical Case: Advanced Squamous Cell Carcinoma Treated with Intravenous and Oral CDS
Three years ago, Dr. Jaramillo was diagnosed with squamous cell carcinoma on the scalp. The primary lesion was surgically removed, but the underlying bone involvement was initially neglected. Over time, a CT scan revealed that the cancer had penetrated the second bony table and was approaching the dura mater. Despite multiple evaluations by oncologists and dermatologists showing no metastasis, treatment options offered included surgery and radiotherapy.
With tumor progression invading large areas of the scalp (including parietal, frontal, and occipital regions) and no effective solutions available, Dr. Jaramillo decided to initiate treatment with chlorine dioxide solution (CDS). The treatment consisted of intravenous administration of 30 cm³ in a saline bag twice daily for five days, followed by daily intravenous doses and continuous oral intake.
The results were remarkable: within five days, the open lesions on the scalp showed complete and healthy healing. Photographic documentation confirmed the rapid clinical improvement. Intravenous treatment continued for ten days, and CDS oral intake is maintained as ongoing therapy.
This case exemplifies the therapeutic potential of CDS to restore electromolecular cell function and promote recovery in complex diseases.
The Jaramillo Soup Program: Innovation in Pediatric Nutrition
Additionally, Dr. Jaramillo describes his experience with the “Jaramillo Soup” program, initiated about 60 years ago with his daughters to feed newborns, both premature and full-term. According to him, this diet—based on a non-exclusive milk formula—has produced outstanding health results, allowing closure of the Pediatrics Department at Hospital La Misericordia in Calarcá for over ten years.
Dr. Jaramillo challenges the common practice of exclusive milk-based feeding, describing it as a serious mistake with irreversible intellectual consequences linked to infant anemia. His investigations, including biopsies on deceased newborns, suggest that digestive immaturity does not justify this practice.
He also highlights studies such as those by Dr. Nevin Scrimshaw demonstrating how infant anemia negatively impacts IQ, emphasizing that the first six months of life are critical for brain development if adequate nutrition is provided.
Dr. Jaramillo is preparing to publish a book compiling his findings and experiences on this subject, which already has international reach.
This testimony reinforces the importance of electromolecular treatment with CDS for complex diseases and introduces an innovative evidence-based approach to pediatric nutrition.
